CClinicalTrials.gg
CompletedNCT07451145SRIMSUpdated Mar 5, 2026

Stress Reduction Program for Iraqi Medical Students

An interventional study of Mindfulness-Based Stress Reduction Program in Psychological Stress and Academic Stress, sponsored by University of Thi-Qar. Completed at 1 site in Iraq. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-05.

Sponsored by University of Thi-Qar · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

A 4-week stress reduction program for medical students during exams, measuring effects on stress, heart rate, blood pressure, and stress hormones (ACTH, cortisol, DHEA).

Read the detailed description

This single-group pre-post intervention study evaluates the effects of a culturally adapted 4-week stress-reduction program on psychological well-being, cardiovascular function, and hypothalamic-pituitary-adrenal (HPA) axis hormones in Iraqi medical students during examinations. A total of 135 medical students participated in an 8-session mindfulness-based stress management program. Primary outcomes included perceived stress (0-10 visual analog scale), heart rate, blood pressure, and serum levels of ACTH, cortisol, and DHEA, measured before and after the intervention.

02

Conditions studied

  • Psychological Stress
  • Academic Stress

Browse trials for

Keywords

  • ACTH
  • Cortisol
  • DHEA
  • HPA axis
  • Stress reduction
  • Stress management
  • Mindfulness
  • Medical students
  • Academic stress
  • Psychological stress
  • Neuroendocrine
  • Iraq
  • Examination stress
  • Behavioral intervention
  • Stress hormones
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • - Medical students at University of Thi-Qar College of Medicine
  • Currently enrolled and preparing for examinations
  • Age 18 years or older
  • Willing to participate in 8 intervention sessions
  • Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Current use of medications affecting HPA axis or cardiovascular function

    • Diagnosed chronic medical or psychiatric conditions
    • Pregnancy or lactation
    • Previous participation in formal mindfulness or stress management training
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
135 participants (actual)

Study arms

  • Experimental
    Stress Reduction Intervention

    All 135 participants receive a 4-week mindfulness-based stress reduction program consisting of 8 group sessions (90 minutes each, twice weekly) plus daily home practice (15-20 minutes). Measurements taken at baseline and 4 weeks.

    Behavioral: Mindfulness-Based Stress Reduction Program

Interventions

  • BehavioralMindfulness-Based Stress Reduction Program

    Culturally adapted 4-week stress reduction program including: * 8 group sessions (2 per week, 90 minutes each) * Mindfulness meditation techniques * Progressive muscle relaxation * Breathing exercises * Psychoeducation about stress * Daily home practice (15-20 minutes) * Led by trained facilitators

05

What researchers measure

Primary outcomes

  1. Perceived Stress Score

    Perceived Stress Score (0-10 visual analog scale)

    Time frame: Baseline and 4 weeks

  2. ACTH Levels

    Measure: Levels (pg/mL)

    Time frame: Baseline and 4 weeks

  3. Cortisol Levels

    Measure: Cortisol Levels (µg/dL)

    Time frame: Baseline and 4 weeks

  4. DHEA Levels

    Measure: DHEA Levels (ng/mL)

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Heart Rate

    Measure: Heart Rate (bpm)

    Time frame: Baseline and 4 weeks

  2. Blood Pressure

    Measure: Blood Pressure (mmHg) - Systolic and Diastolic

    Time frame: Baseline and 4 weeks

06

Study locations

1 site
  • University of Thi-Qar College of Medicine
    Nasiriyah, Thi-Qar 64001, Iraq
07

References and documents

Individual participant data

Plan to share: Yes — Individual participant data collected for all primary and secondary outcome measures, including perceived stress scores, heart rate, blood pressure, and serum hormone levels (ACTH, cortisol, DHEA), along with demographic variables (age, sex) and intervention attendance data.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07451145
Lead sponsor
University of Thi-Qar
Responsible party
Adel Gassab Mohammed (Assistant Professor of Internal Medicine and Endocrinology, University of Thi-Qar) — Principal investigator
First posted
Mar 5, 2026
Start date
Oct 1, 2024
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Last update
Mar 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion